AI assistant
Shilpa Medicare Ltd. Call Transcript 2020
62243_rns_2020-09-02_24588c2d-3a9b-44df-9a48-83c141276552.pdf
Call Transcript
Open in viewerOpens in your device viewer
Shilpa Medicare Limited
Corporate & Admin Office : Innovating for "Shilpa House", # 12-6-214/A-1, Hyderabad Road, affordable healthcare Raichur-584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: [email protected], Web: www.vbshilpa.com CIN: L85110KA1987PLC008739
Dated: 02.09.2020
Corporate Relationship Department, National Stock Exchange of India BSE Limited Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5" Floor, Dalal Street, Fort, Plot No. C/1, G Block Mumbai-400 001 Bandra Kurla Complex, Bandra (E)
MUMBAI-400 051
Dear Sir/Madam,
Sub: Outcome of Schedule of Analysts/ Investors meeting u/r 30 of the SEBI (LODR) Regulations, 2015 - Reg.
Ref: Stock Code: NSE: SHILPAMED/BSE-530549
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company had organized a group call with Analysts / Institutional Investors via Audio/Visual Means on Wednesday, 02 September, 2020, the meeting was represented by Mr. Vishnukant Bhutada, Managing Director of the Company. The meeting held was general investors call.
This is for your information and records.
With Regards,
Vishnukant Chat Managing Direct DIN: 01243391